Dubbed PATHWAY, the solution integrates safety assessment study types and bioanalytical support and can manage the complexity of the entire safety assessment process on behalf of Envigo’s pharmaceutical and biotechnology customers.

Envigo developed the PATHWAY solution to help its customers navigate the increased scientific and regulatory complexity facing advanced therapies going through safety evaluation.

The solution has been designed to leverage Envigo’s capacity, capabilities and experience in the field and deliver translational biology insights to prepare customers for first-in-human clinical trials.

Envigo chief scientific officer Lee Coney said: “Our deep expertise in the complex fields of biologics and advanced therapies adds particular value to our customers with drug development programmes in these growing categories.

“On our customers’ behalf, we frequently work with regulators to determine the most appropriate interpretation of regulatory guidance as it applies to a specific therapeutic.

“PATHWAY makes full use of our beginning-to-end understanding of the safety assessment process, and optimises the journey to first-in-human studies.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Coney further added that the company designs and conducts studies in various therapeutic modalities.

Envigo works with regulatory agencies across the globe and can anticipate the requirements of a programme at the design stage. Accordingly, it plans studies and manages an optimal timeline of study execution.

The company has harmonised facilities with AAALAC accreditation in Europe and North America and further seeks to optimise safety assessment programmes by ensuring studies are carried out at centres of excellence.